Defective Breast Mesh, ADM, and Bioabsorbable Scaffold Injury Attorneys in Pennsylvania: The Definitive Guide for Women and Families
If you are reading this in Pennsylvania, you may be facing one of the most frightening and confusing chapters of your life. Whether you underwent a post-mastectomy reconstruction at an NCI-Designated Comprehensive Cancer Center in Philadelphia or Pittsburgh, or a cosmetic augmentation at a private plastic surgery practice in the Lehigh Valley or the Main Line, you were likely told that the materials used in your body were safe. You were likely told that these surgical meshes, acellular dermal matrices (ADMs), or bioabsorbable scaffolds were the latest standard of care, designed to support your “internal bra” and ensure a beautiful, lasting result.
The reality we now face alongside our clients throughout Pennsylvania is much different. Many women across the Keystone State are discovering that the products used in their reconstructions and augmentations were never actually cleared or approved by the FDA for breast surgery. We understand the pain of reconstruction failure, the fear of an emerging cancer diagnosis like BIA-ALCL or BIA-SCC, and the frustration of needing five, six, or even eight revision surgeries to fix what should have been a path to healing.
At The Manginello Law Firm, PLLC, operating as Attorney911, we have spent decades standing up against institutional giants. Our managing partner, Ralph Manginello, has been licensed for twenty-seven continuous years and is admitted to the United States District Court for the Southern District of Texas, where many of these federal medical device issues are litigated. Our associate attorney, Lupe Peña, brings an invaluable perspective as a former insurance defense lawyer. We know how the other side thinks, we know how they try to minimize your suffering, and we know exactly where the regulatory failures began. If you speak Spanish at home in Pennsylvania, Lupe Peña conducts full consultations in fluent Spanish without the need for an interpreter. We invite you to call us at 1-888-ATTY-911 for a confidential, no-obligation conversation about what happened to your body.
Understanding the Devices: Mesh, ADM, and Scaffolds
To understand your legal options in Pennsylvania, you must first understand the terms your surgeons may have used. These devices generally fall into three categories, though they are often used interchangeably in surgical notes.
Acellular Dermal Matrix (ADM)
ADM is a biologic material derived from human or animal skin. The cells are removed, leaving a “scaffold” of collagen and connective tissue. Brands like AlloDerm (Allergan/AbbVie), Strattice, FlexHD (MTF Biologics), and AlloMax (BD) are commonly used in Pennsylvania hospitals to provide extra support for breast implants or tissue expanders. While they are meant to integrate with your body, they can also become a breeding ground for bacteria or cause sterile inflammation.
Bioabsorbable Scaffolds
These are synthetic, dissolvable meshes designed to provide temporary support while your body builds its own scar tissue. Products like GalaFLEX (Becton Dickinson/Galatea) and Phasix are made of poly-4-hydroxybutyrate (P4HB). These scaffolds are marketed as an “internal bra” to prevent the implant from “bottoming out” or shifting. However, we have seen cases where these materials fail to dissolve as promised, becoming palpable, painful, and prone to infection years after they were supposed to be gone.
Synthetic Surgical Mesh
Sometimes, permanent synthetic meshes—like the polypropylene used in hernia repairs—are used off-label in breast surgery. These materials were never designed for the delicate environment of the breast and can lead to erosion, chronic pain, and permanent disfigurement.
The FDA Regulatory Failure: Why Women in Pennsylvania Weren’t Warned
One of the most shocking facts for our Pennsylvania clients is that the FDA has never cleared or approved surgical mesh specifically for use in breast surgery. Every time a surgeon in Pennsylvania uses one of these products in a breast reconstruction or lift, they are using it “off-label.”
The manufacturers reached the market through a loophole known as the 510(k) clearance pathway. Under 21 USC §360c and 21 CFR Part 807, a company doesn’t have to prove its device is safe or effective through clinical trials. They only have to show it is “substantially equivalent” to a “predicate device” already on the market. We call this “predicate creep.” For example, the manufacturers of GalaFLEX used a surgical suture as a predicate for a mesh that goes inside a woman’s breast.
On November 9, 2023, the FDA issued a critical letter to health care providers. They stated verbatim: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.” This letter named the following BD products: Phasix Mesh, GalaFLEX Lite, GalaFLEX Scaffold, and several others. For many women in Pennsylvania, this letter was the first indication that they had been part of a massive, unmonitored experiment.
The Complication Spectrum: More Than Just a “Difficult Recovery”
If you are experiencing symptoms after a breast procedure in Pennsylvania, you may have been told you’re just a “slow healer” or that your body is having a “normal reaction.” We know that many of these symptoms are actually signs of device failure.
- BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma): This is a specific type of T-cell lymphoma that develops in the capsule around textured implants. It is CD30-positive and ALK-negative. If you noticed a sudden swelling or fluid collection (late seroma) 7 to 10 years after your surgery, this must be ruled out immediately.
- BIA-SCC (Breast Implant-Associated Squamous Cell Carcinoma): A rarer but aggressive cancer that can develop years after both smooth and textured implants. The FDA issued an updated safety communication on this in March 2023.
- Red Breast Syndrome (RBS): This is a sterile inflammation specific to ADM. It looks like an infection—intense redness over the breast—but antibiotics don’t fix it. It is caused by endotoxins (LPS) left on the matrix during manufacturing.
- Reconstruction Failure and Skin-Flap Necrosis: When the mesh or ADM prevents proper blood flow, the tissue itself can die, leading to the loss of the reconstruction and the need for a “flat closure.”
- Capsular Contracture: The scar tissue around the device becomes hard, painful, and can distort the breast shape.
For a woman in Pennsylvania who has already fought breast cancer once, these complications aren’t just medical setbacks—they are traumatic events that affect her body, her bank account, and her family. We take these injuries seriously and approach every case with the technical rigor expected of twenty-seven years of practice. Call us at 888-288-9911 to discuss your specific symptoms and how we can help you document them for a potential claim.
The Pennsylvania Legal Landscape: Deadlines and the “Discovery Rule”
If you are a resident of Pennsylvania, your case is likely governed by 42 Pa.C.S. § 5524, which sets a two-year statute of limitations for personal injury and product liability claims. This means you generally have two years from the date of your injury to file a lawsuit.
However, many complications from breast mesh and ADM don’t appear for five or ten years. Pennsylvania recognizes the “Discovery Rule.” This rule pauses the two-year clock until you knew, or reasonably should have known, that you were injured and that the injury was caused by the conduct of another (the manufacturer). For many Pennsylvania women, the “discovery” date might be the day they read the November 2023 FDA letter, or the day a revision surgeon told them their ADM had been colonized by a biofilm.
Because Pennsylvania is a “Daubert” state, any expert we bring to trial to testify about why the mesh failed must meet strict scientific standards. We have the experience needed to handle these complex evidentiary hurdles. Whether your case belongs in a Pennsylvania state court or a federal district court like the Eastern District in Philadelphia or the Western District in Pittsburgh, we understand the realistic path through the docket to get you the answers you deserve.
The Whistleblower evidence: What the Companies Knew
We follow the work of Dr. Hooman Noorchashm, a cardiothoracic surgeon and former medical director at Becton Dickinson (BD). In 2022, he became a whistleblower, alleging that BD withheld data from the FDA regarding breast cancer recurrences in GalaFLEX clinical trials. He has publicly stated that the malpractice liability for using these devices off-label often falls on the surgeons, while the manufacturers profit from deceptive marketing.
This kind of “Insider Knowledge” is what separates Attorney911 from generalist personal injury firms. We don’t just look for a quick settlement; we look at the regulatory history, the Manufacturer and User Facility Device Experience (MAUDE) database, and the whistleblower record to build an institutional liability case. Success in these cases requires more than just knowing you are hurt—it requires proving the manufacturer knew the risks and chose to remain silent.
Why Pennsylvania Survivors Choose Attorney911
Pennsylvania is home to some of the finest medical institutions in the world, including Penn Medicine’s Abramson Cancer Center and the UPMC Hillman Cancer Center. While these institutions perform miracles every day, the devices they are sold by manufacturers like Allergan or Becton Dickinson are not always up to the same standard.
When you choose us, you are choosing a firm that:
- Holds Verifiable Authority: Ralph Manginello holds an Avvo “Excellent” tier rating of 8.2 and has 5.0 out of 5.0 stars from client reviews. We are currently lead counsel in major institutional litigation, such as the Bermudez v. Pi Kappa Phi case, seeking millions in damages for institutional failures.
- Understand the Language of Science: We speak in terms of CD30 biomarkers, P4HB hydrolysis, and endotoxin-mediated inflammation. We don’t need a medical degree to understand your chart because we have spent twenty-seven years reading them.
- Removes Barriers to Access: With Lupe Peña, we offer a dedicated bilingual advantage. If your primary language is Spanish, you will speak directly to your attorney, not a translator.
- Operates on Contingency: You will never see a bill for our time unless we recover compensation for you. We assume the financial risk of the litigation because we believe in the strength of these cases.
Frequently Asked Questions for Pennsylvania Patients
Is the mesh used in my breast surgery the same as hernia mesh?
Often, yes. Many products like Phasix or Strattice were cleared for hernia repair and then marketed to Pennsylvania surgeons for “internal bra” or breast reconstruction use. They are essentially the same materials used in larger abdominal repairs, now placed in the sensitive breast envelope.
What if I had my surgery in New Jersey but live in Pennsylvania?
This is a common “Access and Travel” scenario. Because the Allergan BIOCELL MDL 2921 is currently centralized in the District of New Jersey before Judge Brian R. Martinotti, your case may well cross state lines. We handle federal court matters and can analyze the choice-of-law issues to ensure your case is filed in the most advantageous venue.
How do I find out exactly what brand was used in me?
By law, Pennsylvania hospitals must retain your operative reports and implant records. You have the right to request a complete “certified” copy of your medical records. Look for “stickers” in the notes—these contain the Unique Device Identifier (UDI), brand name, and lot number. If the hospital is being difficult, we can assist in securing these records for you.
Does health insurance in Pennsylvania cover the removal of these devices?
Under the Women’s Health and Cancer Rights Act of 1998, if your original mastectomy was covered, the treatment of any complications arising from your reconstruction must also be covered. However, many insurers try to deny “explant” or “mesh removal” surgery as “cosmetic.” We fight these denials by presenting the evidence of medical necessity based on the FDA’s own warnings.
What is the average payout for a breast mesh lawsuit?
While no two cases are the same, we look at precedents. In the hernia mesh litigation, corporate giant Becton Dickinson (BD) recently agreed to a settlement in the range of $1 billion for roughly 40,000 claims. In major plastic surgery malpractice cases involving permanent disfigurement, verdicts frequently reach the seven-figure mark. We pursue maximum compensation for your medical bills, future surgeries, lost wages, and the profound pain and suffering you have endured.
Take the First Step Toward Justice
You have fought hard enough already. If you were a patient in a Pennsylvania hospital and you are now living with the consequences of a defective mesh, matrix, or scaffold, you are not just a statistic. You are a woman whose trust was betrayed by a multi-billion dollar manufacturer that put profits over patient safety.
We are ready to listen to your story. Whether you are in Philadelphia, Pittsburgh, Allentown, Erie, or anywhere in between, help is available. Call Attorney911 at 1-888-ATTY-911 (1-888-288-9911) for a free, confidential consultation. As Ralph Manginello often says in our podcast, “the law should protect the victim, not the institution.” We are here to make sure that happens for you.
Hablamos español. Si usted o un ser querido ha sido lesionado por una malla mamaria defectuosa en Pennsylvania, llame a Lupe Peña al 1-888-ATTY-911 para una consulta gratuita y confidencial.
Disclaimer: This content is for educational purposes only and does not constitute legal advice. Past results, including the firm’s history of multi-million dollar recoveries, do not guarantee future outcomes. Completion of a consultation does not create an attorney-client relationship. All claims are subject to the specific facts of the case and the applicable statute of limitations.
